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ABSTRACT
Mycobacteriophage (phage), are viruses that infect bacteria. All bacteria can be
infected by phage, and each bacterial species has a unique set of phage that infect them,
making phage prime candidates for studying viral diversity and evolution. Some phage
integrate their genome into the host genome upon infection (prophage), where they may
potentially remain indefinitely, coevolving with the host, and providing growth factors
and other benefits to the host. The purpose of my research is to characterize a prophage
within the genome of the bacterial host Mycobacterium chelonae Bergey to determine if
it is still functional and potentially impacting the fitness of the host bacterium.
Characterization of this prophage has revealed that multiple genes are conserved with
regard to both the DNA and protein sequences. The integrase cassette is highly
conserved, complete with integrase and two potential repressors, suggesting the phage
may be capable of excising from the host genome. Multiple structural genes including
capsid and tail proteins are also conserved, suggesting the prophage may be capable of
producing intact virions. At least two prophage genes are transcriptionally active. These
include a predicted repressor and transmembrane protein. Expression of these genes
suggests that the prophage does indeed have some potential for affecting the biology of
the host bacterium. Experiments are currently underway to determine if intact virion
particles are being produced during bacterial growth.

ACKNOWLEGEMENTS
I would first like to thank my advisor, Keith Hutchison, for his guidance and
support through the past four years. This thesis began as a much smaller project from my
freshman year of college, and has grown with the help of Keith’s encouragement and
expertise. Weekly meetings with Keith have always resulted in new ideas and never fail
to end without a smile.
Next I would like to thank Sally Molloy for her help during lab meetings and in
the lab over the course of this project. I would like to thank my thesis committee
members for their time and advice.
I would like to thank my sources of funding which include the Honors College
Comparative Functional Genomics Thesis Fellowship and Junior Year Research Award
under NIH-INBRE Grant 8P20GM1003423-12 through the Maine INBRE program, and
the 2016-17 Charlie Slavin Undergraduate Research Grant.
Lastly, I would like to thank my family for their un-ending love and support. My
parents, Jon and Kelley Sewell, have encouraged and inspired me from the beginning.
My sister, Marissa Sewell, has been a life-long best friend and cheerleader. My
grandparents, Dorothy and Keith Kinney, have provided wisdom and hugs especially
during the tough times. I would not be where I am today without such wonderful people
to surround myself with.

iii

TABLE OF CONTENTS
LIST OF TABLES ............................................................................................................ vii
LIST OF FIGURES ......................................................................................................... viii
1.0 Introduction ................................................................................................................... 1
2.0 Literature Review.......................................................................................................... 3
2.1 History of Bacteriophage Research .......................................................................... 3
2.2 Significance of Mycobacterium smegmatis and Mycobacterium chelonae .............. 4
2.3 Introduction to coevolution of phages and their bacterial hosts ............................... 5
2.4 Well known and studied phage toxins conserved in bacteria ................................... 6
2.5 Phage encoded genes in Mycobacterium tuberculosis.............................................. 8
2.6 Significance of toxin-antitoxin systems .................................................................... 9
2.7 Significance of phage-encoded transmembrane proteins and repressor proteins as
contributors to superinfection immunity....................................................................... 10
3.0 Materials and Methods ................................................................................................ 11
3.1 Bioinformatic Analysis ........................................................................................... 11
3.2 Growth of Bacterial Strains .................................................................................... 12
3.3 DNA Isolation ......................................................................................................... 12
3.4 Primer Design ......................................................................................................... 13
3.5 Polymerase Chain Reaction .................................................................................... 15
3.6 Agarose Gel Electrophoresis................................................................................... 15
3.7 DNA Sequencing .................................................................................................... 15
3.8 RNA Isolation ......................................................................................................... 15

iv

3.9 cDNA Synthesis ...................................................................................................... 16
3.10 Spot Testing .......................................................................................................... 16
4.0 Results ......................................................................................................................... 17
4.1 M. smegmatis MC2 155 contains two prophage regions. ....................................... 17
4.2 M. smegmatis MC2 155 predicted prophage gene expression changes during
lysogenic and lytic infection by phage Ukulele. ........................................................... 20
4.3 An intact prophage was found in M. chelonae Bergey. .......................................... 23
4.4 M. chelonae Bergey prophage contains two ORF’s containing DNA-binding
domains. ........................................................................................................................ 25
4.5 M. chelonae Bergey prophage contains multiple transmembrane proteins. ........... 29
4.6 M. chelonae Bowfin does not contain the prophage in the same position. ............. 34
4.7 M. chelonae Bowfin attB site is identical to M. chelonae Bergey attB. ................. 34
4.8 M. chelonae Bergey attB is highly conserved in singleton DS6A and in clusters K
and F.............................................................................................................................. 34
4.9 Prophage transmembrane protein and repressor are transcriptionally expressed in
Bergey. .......................................................................................................................... 36
4.10 No infectious phage particles were detected using spot testing. ........................... 36
5.0 Discussion ................................................................................................................... 38
5.1 M. smegmatis MC2 155 prophage region 1 has strong potential to have
transcriptional regulatory action during and after infection. ........................................ 38
5.2 The M. chelonae Bergey prophage may provide superinfection immunity against
DS6A, and clusters F and K.......................................................................................... 38
5.3 The M. chelonae Bergey prophage integration is recent. ....................................... 39

v

5.4 The M. chelonae prophage has the potential to affect the biology of the host. ...... 39
5.5 Conclusions and Future work ................................................................................. 40
REFERENCES ................................................................................................................. 42
APPENDIX ....................................................................................................................... 47
BIOGRAPHY OF THE AUTHOR................................................................................... 51

vi

LIST OF TABLES
Table 1. Primer sequences and parameters………………………………………………14
Table 2. M. chelonae prophage coordinates, direction, and predicted functions……..appx.

vii

LIST OF FIGURES
Figure 1. Prophage regions 1 (A) and 2 (B) gene maps……………………………….…18
Figure 2. M. smegmatis prophage region 1 RNAseq data………………………..…..….21
Figure 3. Prophage region 1 gene expression is modulated during lysogenic and lytic
infection………………………………………………………………………...………..22
Figure 4. Gene map of the M. chelonae Bergey prophage……………....................……24
Figure 5. Predicted folding structure of M. chelonae prophage repressor gp54 (A)
compared to known folding structure of M. tuberculosis EspR (B).…….…………..…..27
Figure 6. Predicted secondary structure of gp54 compared to known secondary structure
of M. tuberculosis EspR…………...……………………………………………………..27
Figure 7. Predicted folding structure of M. chelonae prophage repressor gp55 (A)
compared to known folding structure of Lambda phage repressor DNA binding domain
(B)………………………………………………………………………………..………28
Figure 8. Predicted folding structure of gp55 compared to known secondary structure of
Lambda repressor DNA binding domains…………………………………………..…...28
Figure 9. Predicted alpha helix membrane spanning domain in gp3…………………….31
Figure 10. Predicted tertiary structure of gp3 (A) compared to known crystal structure of
a putative dehydratase from the NTF2-like family from Streptomyces avermitilis (B)…31
Figure 11. Predicted alpha helix membrane spanning domains in gp67………………...32
Figure 12. Predicted tertiary structure of gp67 (A) compared to known crystal structure of
the core domain of stomatin from Pyrococcus horikoshii (B)…………………………...32
Figure 13. Agarose gel electrophoresis of PCR products screening for prophage presence
in M. chelonae strains…………………..………………………………………………..35

viii

Figure 14. Agarose gel electrophoresis of RT-PCR products using M. chelonae Bergey
RNA as template…………………………………………………………………………37

ix

1.0 Introduction
Phage are viruses that infect bacterial hosts. There are an estimated 1031 phage in
the environment, making phage the most abundant biological entity on earth (18). The
1031 phage can be divided up into an estimated 100 million different species of phage,
each with genomes ranging from 15,000 bp to 165,000 bp in length. This high level of
genetic diversity makes them prime candidates for research in the areas of genomics and
evolution. Mycobacteriophage are a group of phage that infect the genus Mycobacterium.
These viruses are divided into groups known as clusters based on genome similarity.
There are currently 1366 sequenced phage, which are divided up into 26 different clusters
(A-Z) and subclusters (18). Mycobacteriophage replicate by injecting their DNA into a
host cell, then follow one of two different life-cycles; lytic or lysogenic. In the lytic
pathway the viral DNA circularizes and uses the host cell machinery to produce progeny,
eventually lysing the cell and releasing new viruses into the environment. For the
lysogenic pathway, the viral DNA is incorporated into the host genome, and replicates as
part of the host genome when the cell divides. Integrated phage are called prophage, the
infected host is known as a lysogen. When the host cell is under stress, the phage genome
will excise from the host genome and enter into the lytic pathway. However, if the host
bacterium does not encounter a stressful environment, the integrated prophage has the
opportunity to remain and co-evolve along with the host. Selective pressure will dictate
which phage genes are conserved and will retain their function, and which phage genes
are silenced and eventually lost.
It is not uncommon for bacterial genomes to contain prophage or vestigial
prophage. Many of the most highly pathogenic strains of bacteria, including Escherichia
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coli 0157 and Vibrio cholerae, have retained and utilized certain phage genes such as
toxins to increase their pathogenicity in hosts (32, 42). Over time after integration,
prophage genomes may begin to decay, mutate, and rearrange. It has been hypothesized
that by retaining key phage genes, such as repressors, transmembrane proteins, and toxinantitoxin systems, the bacteria enters into a state of superinfection immunity where it is
protected from further infection by other phage. This and other possible advantages have
been proposed as an explanation for why the host bacteria would retain viral genes.
This line of research began with the discovery and characterization of two small
prophage regions in Mycobacterium smegmatis MC2 155, both fewer than 11,000 bp in
length. This strain is used in the SEA-PHAGES course to isolate novel
mycobacteriophage from the environment (23). These prophage regions were
characterized and primers were designed to determine transcriptional expression of the
phage-encoded transposase gene, with no evidence of expression found. This thesis
includes a summary of the characterization of the M. smegmatis MC2 155 prophage
regions, as well as RNAseq analysis for the bacteria.
During the course of this study the genome of M. chelonae Bergey became
available for analysis and focus shifted from the M. smegmatis prophage regions to this
newly sequenced genome. M. chelonae Bergey contains an intact prophage consisting of
95 open reading frames, of which at least two are transcriptionally active. The prophage
is organized as most mycobacteriophage appear within the host, with structural and
assembly genes on the left arm and nonstructural and replication genes on the right arm
(18). Investigation of this prophage has provided insights into the function and role of
mycobacteriophages in the superinfection immunity and virulence of their bacterial hosts.
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The discovery of M. chelonae’s prophage represents yet another phage-host combination
with which to better understand the effects of viral infection and lysogeny on individual
bacterial hosts and on total bacterial populations.

2.0 Literature Review
2.1 History of Bacteriophage Research
Bacteriophages were co-discovered in 1915 and 1917 by Frederick Twort and
Felix d’Herelle respectively. D’Herelle coined the name bacteriophage using the root
Greek word “phagein” meaning to eat, with the name bacteriophage literally meaning
bacteria-eater. The first mycobacteriophage was isolated with M. smegmatis in 1947.
Mycobacteriophages were thought to be very limited in total effect on bacterial
populations because of the comparatively late discovery of this type of virus (13).
However soon after this initial discovery, mycobacteriophages that infected M.
tuberculosis were discovered (12) and mycobacteriophage research began to greatly
increase.
Mycobacteriophage have traditionally been involved in typing strains of bacteria,
particularly clinical isolates of Mycobacteria. Early on in molecular biology,
mycobacteriophage were used as tools to alter and manipulate gene expression in the host
bacteria. In the 1980’s mycobacteriophage were used as shuttle vectors which could be
manipulated in E. coli and used to deliver novel DNA to mycobacteria. (19). This type of
research holds great promise in better understanding the physiology and virulence of
mycobacterial hosts.
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Phage therapy is a particularly interesting area of bacteriophage research. It
involves exploiting the ability of phages to lyse and destroy bacteria as a result of their
lytic infectious cycle in order to fight off infectious bacterial diseases. This treatment
could be a valuable tool in fighting off bacterial culprits such as tuberculosis, especially
in light of the antibiotic resistance crisis. Most early experiments in this area of research
were unsuccessful in treating tuberculous diseases. However in some parts of the world,
particularly in eastern Europe, phage therapy is commonly used preventatively and in the
treatment of purulent and enteric pathogens (26). More clinical trials are needed to
expand knowledge and use of phage therapy as a legitimate treatment option in more
countries.
In 2008 the SEA-PHAGES program introduced the use of mycobacteriophage as
a learning tool in the college-level STEM curriculum (23). To date, 1366 unique
mycobacteriophage genomes have been sequenced, offering valuable insight into
evolution, particularly phage-host coevolution, and the effect these small DNA viruses
have on modulating and controlling the total mycobacterial population. Powerful
computational analysis combined with traditional molecular biology has revealed great
diversity in mycobacteriophage (17). These tools have also allowed researchers to ask
broader questions about mycobacteriophage evolution, and coevolution, with their
mycobacterial hosts.
2.2 Significance of Mycobacterium smegmatis and Mycobacterium chelonae
M. smegmatis is a common largely non-pathogenic soil bacterium that may safely
be used to isolate novel mycobacteriophage. It has been reported as a human pathogen in
very rare instances including traumatic injury or surgery and is known as a rare pathogen
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in immunocompromised patients (33). M. smegmatis is well studied and has been the
subject of many research articles. This bacterium was therefore the first used in this
research to study the coevolution between mycobacteriophages and their hosts.
M. chelonae is a fast growing non-tuberculous bacteria that commonly causes
infection after intrusion or injury to the skin, such as plastic surgery or injections (43). It
is also an opportunistic pathogen in individuals with HIV/AIDS and those with lung
cancer and lung diseases (44). M. chelonae is a member of a group of mycobacteria that
includes M. abscessus and M. fortuitum. Infections with these mycobacteria are
notoriously difficult to treat as a majority are resistant to tetracyclines and most other
antimicrobial agents (37). This bacterium is more commonly known for its role as a fish
pathogen and is one causative agent of piscine mycobacteriosis, along with M. marinum
and M. fortuitum (14).
M. chelonae was originally isolated in 1923 from a tortoise tubercule by David
Hendricks Bergey, author of Bergey’s Manual of Determinative Bacteriology. The draft
M. chelonae Bergey genome sequence was published in GenBank in 2015 (16). A more
complete sequence was published in 2016 (21).
2.3 Introduction to coevolution of phages and their bacterial hosts
Upon infection and entrance into the lysogenic lifestyle, phages are thought to lay
dormant, simply replicating as part of the host genome. However further investigation has
revealed that prophage can have a significant impact on the fitness and pathogenicity of
their bacterial hosts.
As mentioned earlier, there is an absence of selective pressure in the bacterium to
maintain functionality of phage DNA that does not confer any fitness factors to the host.
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This results in defective or “cryptic” prophage regions, where genes coding for phage
specific functions such as lysis and phage-particle formation are no longer complete and
functional. Some prophage code for so-called fitness factors, such as toxins, that benefit
the host with increased pathogenicity or superinfection immunity. These genes have been
shown to be conserved and expressed within multiple bacterial hosts including V.
cholera, E. coli and Staphylococcus aureus (15). It is interesting to note that the most
virulent strains of bacteria often contain prophage remnants or phage encoded toxins.
Toxin genes are the most well-known phage-encoded genes known to confer increased
virulence to the host. Other examples of beneficial phage-encoded genes include toxinantitoxin systems, which provide the benefit of an apoptosis-like response to cells. This
acts to limit total viral infection in a bacterial population (11). Superinfection immunity
can be provided to the host by phage-encoded transmembrane and repressor proteins (40,
9).
2.4 Well known and studied phage toxins conserved in bacteria
V. cholerae is a gram-negative bacteria that normally resides in brackish water.
When ingested by humans, V. cholera causes the disease cholera which is characterized
by severe dehydration, diarrhea, and vomiting. Cholera has two main virulence factors,
the cholera toxin (CT) and toxin-corrugated pili (TCP) which lie on the phage CTXφ.
This phage is known to code for at least 6 genes including cholera toxin subunits A and
B, a core-encoded pilin, as well as an accessory cholera enterotoxin. V. cholerae’s
notable virulence is due to this phage-encoded pili, which allows establishment of the
bacterium in the intestinal epithelium. The CTXφ element is capable of producing phage
particles which present as curved bundled filaments under electron microscopy. These
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phage particles have been shown to contain single stranded DNA corresponding to the
CTXφ element (42).
Enterohemorrhagic E. coli 0157:H7 produces the phage encoded shiga toxin,
which is the cause of a type of food poisoning in humans known as hemorrhagic colitis.
This illness is characterized by painful cramping, dehydration, and diarrhea and can be
deadly if left untreated (22). The shiga toxin is a type of exotoxin that originates from a
group of phages known as stx (shiga toxin) converting phages (38). Lysogenization of
novel E. coli strains with stx converting strains successfully converts these strains to
produce functional shiga exotoxins (30).
Another significant example of phage encoded toxins in Gram positive bacteria is
the exfoliative toxin in S. aureus. If infected with this pathogen, young children will
develop skin splitting caused by exfoliative toxins A and B (ETA and ETB). ETA is
located directly on the bacterial chromosome while ETB is located on a separate plasmid
(45). These phage encoded exotoxins exhibit super antigenic capabilities, indicating the
potential for dual functionality (6). In the ETA producing strain S. aureus E-1, mitomycin
C was used to induce phage particle production of phage φETA. Phage particles complete
with a hexagonal head and flexible tail fibers were visualized under electron microscopy.
The 43081 bp phage genome was sequenced and found to contain several highly
conserved genes including integrase, a repressor, and the gene encoding ETA which was
located at the end of the phage genome near attP. Other strains of S. aureus were
converted to ETA producers after becoming φETA lysogens (45).
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2.5 Phage encoded genes in Mycobacterium tuberculosis
M. tuberculosis is often associated with the extreme morbidity and mortality that
it causes in third world populations and in immunocompromised individuals. It is the
most well-known member of the Mycobacterium of the tuberculosis complex, otherwise
known as the causative agents of human and animal tuberculosis. This illness is
characterized by symptoms including chronic cough, blood in the sputum, and weight
loss. M. tuberculosis bacteria will make way to the lungs and become engulfed by
immune cells such as macrophages. The phagocytosed M. tuberculosis bacterium
possesses a thick mycolic acid capsule that protects it from destruction by reactive
oxygen species and acids inside the macrophage. The bacteria is then capable of
reproduction inside the immune cell and will go on to eventually kill the cell. This
process continues while all types of immune cells migrate to the site of infection, but
when new macrophages migrate and attempt to engulf and destroy the infected
macrophage, the two fuse and form an aggregated multi-nucleated cell, otherwise known
as a granuloma. Eventually immune cells build up around multiple granulomas and form
the key characteristic of an active tuberculosis infection, a tubercule.
There are two M. tuberculosis strains of significance in explaining the role of
phage genes in the biology of Mycobacteria, M. tuberculosis H37Rv, a well-studied
laboratory strain, and CDC1551, a clinical isolate. M. tuberculosis H37Rv contains a
9427 bp region, RD3, that is not found in Mycobacterium bovis, which is an avirulent
strain used to make a vaccine against M. tuberculosis. Within this RD3 region are five
genes with similarity to phage genes encoding protein capsid, protease, terminase,
primase, and integrase, together collectively known as phiRv1. This segment of phage-
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like similarity is too stunted to be able to produce fully intact phage particles, but is
interesting because it lies in a repetitive element REP13E12 that is repeated seven times
throughout the genome. In M. tuberculosis CDC1551, a nearly perfect copy of phiRv1 is
also present, but lies in a different REP13E12 repeat. Subsequent experiments showed
that the phiRv1 is mobile element capable of integration and excision in and out of the
REP13E12 repeats. M. tuberculosis H37Rv contains a second prophage element, phiRV2,
integrated at a different REP13E12 repeat. It is not yet known what function these mobile
phage elements have in the M. tuberculosis genome, but it is possible that these mobile
elements are in some way beneficial to the bacterium due to the strong conservation of
both sequence and function in this seemingly derelict prophage (4).
2.6 Significance of toxin-antitoxin systems
Toxin-antitoxin (TA) systems are found in bacterial genomes and are thought to
function as an anti-bacteriophage defense, in addition to playing other cellular roles. TA
systems promote cell death during infection to limit overall phage infection in the
bacterial population. In RNA-RNA systems, the antitoxin will inhibit the translation of
the toxin, thereby suppressing a cell death response. The toxin is translated only when the
antitoxin has been degraded in response to some stressor. Free toxins target and lead to
the inhibition of central cell processes such as DNA replication. Inhibition of these
crucial mechanisms eventually leads to an “altruistic” cell death in the case of viral
infection (10). Phage are known to carry these types of systems as a resistance
mechanism against the host TA systems (8). Although it has not been shown
experimentally, it can be hypothesized that a prophage encoded TA system would offer
the host protection against subsequent phage infections.
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2.7 Significance of phage-encoded transmembrane proteins and repressor proteins
as contributors to superinfection immunity
Superinfection immunity is the state in which a lysogen is immune to infection by
viruses that are genetically similar to the currently integrated prophage. To understand
the mechanism behind superinfection immunity, the decision between lytic and lysogenic
life cycles must first be understood. Phage Lambda lysogeny is one of the most highly
characterized systems. The decision in Lambda between the two life cycles, lytic or
lysogenic, depends on the amounts of two different phage-encoded proteins; Cro and CI.
When CI prevails and binds to the operator regions OR, the lysogenic lifecycle will
initiate and the phage will integrate into the host genome. After integration, the CI
repressor is produced to maintain lysogeny and also acts to recognize and bind to the
DNA of genetically similar viruses, marking them for destruction (9). This hinders
infection by other viruses and acts as a mutually beneficial defense for both phage and
host by offering the host protection from other phage that may infect, enter the lytic
cycle, and destroy the cell.
Phage encoded transmembrane proteins have been shown to provide
superinfection immunity to the host bacteria by interfering with viral binding and
injection of viral genomic material through altering the appearance of the host cell
membrane. This has been shown in a Streptococcus thermophilus lysogen with temperate
phage TP-J34 where the phage-encoded ltp gene, a lipoprotein, was associated with the
cell membrane. The ltp protein provided limited superinfection immunity by presenting
on the outside of the cell and interfering with phage DNA release and/or injection.
Complete immunity was not provided, but plaque formation in lysogens was reduced by a
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factor of 40 (40). Phage-encoded transmembrane proteins have also been found to
provide superinfection immunity in E. coli where gp15 of the HK97 prophage was
expressed and located on the inner bacterial membrane. This transmembrane protein was
predicted to interact with the incoming phage tail to prevent the formation of a channel
through the cell membrane. This particular example is interesting because unlike
traditional repressor-mediated immunity, gp15 has been found to provide immunity
against phage belonging to different immunity groups (7).

3.0 Materials and Methods
3.1 Bioinformatic Analysis
A number of different software packages and online databases were used over the
course of this project. NCBI (31) was used to access nucleotide sequences and to utilize
the BLAST functions blastn and blastp. This program was used to find gene functions
during characterization of the prophage regions, and to compare attP and attB sequences.
Phast (46) is a program that references two different protein databases; the NCBI phage
database, and a separate database including other proteins from phage genomes not
included in NCBI. Phast was used to identify potential prophage regions and to access
nucleotide and amino acid sequences for predicted genes. Phyre2 (24) predicts and
analyzes protein structure based on a given amino acid sequence. It was used to predict
function and to visualize folding structures of prophage amino acid sequences. HHpred
(39) references multiple protein structure databases to detect structural homology and
subsequently predict potential protein function. It was used to assist in assigning potential
functions to prophage genes. GenemarkS (3) was utilized to predict coding potential for
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prophage open reading frames, and was used to generate nucleotide and amino acid
sequence files for all potential M. chelonae Bergey prophage genes.
3.2 Growth of Bacterial Strains
M. chelonae strains, Bergey, and isolates from Fat Head Minnow, flounder (F5),
and Bowfin were grown at 30°C with shaking in 7H9 media, supplemented with OAD
supplement (oleic acid 0.05%, bovine serum albumin 5%, dextrose 2%) and 50 µg/ml
carbenicillan (CB) and 10 µg/ml cyclohexamide (CX) or on OAD 7H10 agar plates.
3.3 DNA Isolation
Mycobacterial DNA was isolated by harvesting cells from exponential to late log
bacterial cells. These cells were centrifuged at maximum speed for 1 min and pellets
were resuspended in 0.5 mL of lysis buffer (50 mM Tris-Cl, 5 mM EDTA, pH 8,
lysozyme 1 ng/µl). The solution was incubated for 1.5 hrs at 37 °C. Afterwards, 50 µl
10% SDS page were added, tubes were mixed by inversion, and 2.5 µl proteinase k (20
mg/ml) were added to each tube. Solutions were incubated at 65 °C for 10 min. DNA was
extracted using equal volumes of TE (10mM Tris, 1mM EDTA, pH 8.0) saturated phenol
and chloroform and tubes were vortexed and centrifuged for 3 min at maximum speed at
room temperature. The aqueous layer was transferred to a clean 2 ml microcentrifuge
tube and one half volume of 7.5 M ammonium acetate and 2 volumes of 100% ethanol
were added. The solution was vortexed and incubated overnight at -20 °C, then
centrifuged at 20,000 x g for 30 min at 4 °C. The supernatant was removed and the pellet
was washed with ice cold 70% ethanol. The pellet was allowed to dry and then was
resuspended in TE.
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3.4 Primer Design
All primers were designed using the web program Primer3Plus (37). Two sets of
primers were designed to amplify the left and right ends of the integrated prophage in M.
chelonae strains. Each set of primers contained one primer flanking the prophage by
~250 bp away from the attL or attR sequence and one primer within the prophage
sequence ~250 bp away from the attL or attR sequence. Gene specific primers were
designed to amplify prophage genes of interest. Specific primer sequences and
parameters can be found in Table 1.
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Table 1. Primer sequences and parameters.
Primer Name

Oligo Sequence (5’ – 3’)

Melting
Temperature

MCProphageLF

TCCTCGTTCTCGTACA
CCTTC
CACTCGTACGGCTTG
ACG
GACATCAACACCCCC
GACTA
ATAACTTTCGGCGGTT
CCTT
ACACTCGGCAAGCTG
TTCTT
GGACGGCAGAGCATA
GTTTC
TGATCCACAAGGCAT
ATCCA
CATCCGAGCACTACC
ATCCT
TATGTTGCGCTTGCGA
TTAG
TGGGATTTCCGAGTT
ACCAG
TCAACGTGAAGCTCG
ATGTC
GGCACTTTCAGTGTCC
CTGT
TCGAGGTCAAGAACC
TACCG
GGGCTGAAAAAGATT
CGACA
CATCGACTACGACCA
GCAGA
TTCTCCAGCGACTTCT
GGAT

56

Primer Expected
Length cDNA
length
21
-

55.9

18

-

56.5

20

-

54.5

20

-

57.2

20

MCProphageLR
MCProphageRF
MCProphageRR
McProphage_gp3F
McProphage_gp3R
McProphage_gp7F
McProphage_gp7R
McProphage_gp52F
McProphage_gp52R
McProphage_gp54F
McProphage_gp54R
McProphage_gp55F
McProphage_gp55R
McProphage_gp67F
McProphage_gp67R

14

162 bp
55.8

20

53.6

20
150 bp

56.4

20

53.5

20
198 bp

54.4

20

55.0

20
202 bp

57.6

20

56.1

20

53.2

20

56.4

20

55.7

20

217 bp

188 bp

3.5 Polymerase Chain Reaction
PCR was performed in 25 µl volumes containing 1 ng mycobacterial DNA,
0.5µM of each primer, and Promega PCR mastermix with Taq polymerase (Promega,
Madison, WI). Reactions were incubated as follows; 95 °C for 5 min, then cycled 35
times at 95 °C for 30 s, 55 °C for 40 s, 72 °C for 1 min, then finally 72 °C for 5 min and 4
°C indefinitely.
3.6 Agarose Gel Electrophoresis
Nucleic acid PCR products were fractionated on 1.5% (w/v) SeaKem Agarose
(Lonza, Basel, Switzerland) gels, which were stained with ethidium bromide (0.5 mg/ml).
The following were added to each well for a total volume of 10µl; 4µl nucleic acid
sample, 4µl nuclease-free water, and 2µl loading dye. For ladders, the following were
added to each well for a total of 10µl; 7µl nuclease-free water, 2µl loading dye, 1µl 100bp
ladder. Gels were run in TAE buffer (40 mM Tris, 20 mM acetic acid, 2 mM EDTA) at a
constant voltage of 90 to 110 V. Gels were visualized under UV light.
3.7 DNA Sequencing
Samples to be sequenced were prepared in sterile water at a concentration of
10ng/µL and sent to the UMaine DNA Sequencing Facility. The facility is equipped with
an ABI 3730 DNA Sequencer with the XL Upgrade. Primers were provided at a
concentration of 5µM.
3.8 RNA Isolation
Five ml cultures were grown to saturation and used to inoculate two 50 ml
cultures. These were grown to OD600 of 1 overnight. Cells were centrifuged for 3 min at
5500xg at room temperature. Supernatent was saved and the pellet was resuspended in
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phage lysate at an MOI of 3 and incubated for 10 min at room temperature. One cell
pellet was resuspended in phage buffer for a control. The remaining supernatant was
poured back into the flask after 10 min and incubated in a shaker at 37 °C. Cells were
harvested in triplicate at 0 min from the control flask, and from virus-treated flasks at 30
and 150 min. In triplicate for each time point, 3 ml of cell culture were added to 6 ml of
RNA Protect Bacteria Reagent (Qiagen, Valencia, CA) in conical tubes, vortexed for 5
sec, and incubated at room temperature for 5 min. Samples were centrifuged for 1 min at
5000xg and supernatant was removed. RNA was isolated from cell pellets and was
resuspended in 100 µl RNAse-free TE containing 100 µg/ml lysozyme using the RNeasy
Mini Kit according to the manufacturers recommendations (Qiagen) During isolation,
RNA was treated with DNAse using the RNAse-free DNAse set (Qiagen). After RNA
isolations were complete, RNA was treated a second time with DNAse using the Turbo
DNA-free kit (Life Technologies, Thermo Fisher, Waltham, MA) according to the
manufacturers recommendations.
3.9 cDNA Synthesis
Mycobacterium chelonae Bergey cDNA was made from RNA using the iScript
Reverse Transcription Supermix kit according the manufacturer recommendations (BioRad Laboratories) to conduct RT-PCR.
3.10 Spot Testing
Spot testing was conducted by inoculating 4.5 ml of warm 7H10 agar with 0.5 ml
of M. chelonae Bowfin culture and plating on agar plates. After plates had cooled, 10 µl
M. chelonae Bowfin culture was pipetted onto the plates at 100, 10-1, 10-2, and 10-3
dilutions.

16

4.0 Results
4.1 M. smegmatis MC2 155 contains two prophage regions.
M. smegmatis MC2 155 contains two prophage regions each less than 11,000 bp
in length. Prophage region 1 (Figure 1A) spans 10663 bp and consists of 10 genes of
differing levels of sequence similarity, including predicted transposase genes, and a
region of divergent transcription containing multiple transcriptional regulators and
regulators of DNA synthesis. Genes MSMEG_1872 through MSMEG_1875 are related
to corresponding genes in M. tuberculosis. MSMEG_1872 appears to be a component of
a well-known gene cluster in M. tuberculosis, ESAT-6, that encodes a type VII secretion
system which promotes cell to cell migration during infection (1, 21). MSMEG_1874 and
MSMEG_1875 are homologous to MtrA and MtrB (28) which is a two-component
system found in Cornebacterium, Mycobacterium, and M. tuberculosis in particular, that
responds to environmental stress and regulates cell wall permeability (29). The MtrAB
system has been shown to be especially important in regulating growth during M.
tuberculosis infection of macrophages (11). It should be noted that the MtrAB system is
conserved in both M. tuberculosis and M. leprae but are surrounded by different genes,
indicating that the prophage either brought the MtrAB system to M. smegmatis, or the
phage integrated adjacent to this two component system. Prophage region 2 (Figure 1B)
spans 8571 bp. This region contains fewer readily identifiable phage genes, but does
contain 9 total genes including conserved phage proteins such as endolysin and an
isomerase.
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MSMEG_1874: DNAbinding response
regulator MTRA
MSMEG_1873:
DTMP kinase

A.

MSMEG_1875:
MSMEG_1872: ESAT- Histidine kinase
MTRB
6-like protein

MSMEG_3434:
Isomerase

B.

MSMEG_3433:
Glucose oxidase

MSMEG_3437:
Endolysin

Figure 1. Prophage regions 1 (A) and 2 (B) gene maps. Forwardly transcribed genes
are represented by forward facing arrow, genes transcribed in reverse are represented by
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backward facing arrows. General predicted gene functions can be found using the color
key at the bottom of the figures. Gene maps were generated using Phast (46).
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4.2 M. smegmatis MC2 155 predicted prophage gene expression changes during
lysogenic and lytic infection by phage Ukulele.
RNAseq data recently became available for M. smegmatis MC2 155 courtesy of
the Molloy laboratory. This data includes the quantification of mRNA and tRNA from M.
smegmatis lysogens of mycobacteriophage Ukulele, and RNA isolated from lytic
infections of M. smegmatis with Ukulele at 0 (uninfected), 30 and 150 min post infection.
This data was initially visualized using the Integrative Genomics Viewer (35) to compare
expression levels (Figure 2).
The expression of multiple prophage encoded genes changes in the Ukulele
lysogen compared to the uninfected control. Prophage genes MSMEG_1873,
MSMEG_1874, and MSMEG_1875 are all downregulated in the Ukulele lysogen, while
MSMEG_1872 is slightly upregulated. All four prophage genes are downregulated 30
min post infection with Ukulele. At 150 min post infection MSMEG_1872,
MSMEG_1873, and MSMEG_1874 return to nearly the same expression levels as in the
uninfected control while MSMEG_1875 is upregulated, but still falls below expression
levels of the control (Figure 3).
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Figure 2. M. smegmatis prophage region 1 RNAseq data. The entire prophage region 1
is shown, with the uninfected control in the top panel compared to the Ukulele lysogen in
the bottom panel. Forwardly transcribed reads are shown in purple. Visualization of the
RNAseq data was done using the Integrative Genomics Viewer (35).
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M. smegmatis Prophage Region 1 Genes

Figure 3. Prophage region 1 gene expression is modulated during lysogenic and lytic
infection. Down-regulation is represented by a negative log fold change, up-regulation is
represented by a positive log fold change. Insignificant values are denoted by an asterisk.
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4.3 An intact prophage was found in M. chelonae Bergey.
Analysis of the newly sequenced M. chelone Bergey genome with Phast (46)
revealed a region spanning 68, 224 nucleotides (Figure 4), containing 95 open reading
frames with significant similarity to phage genes. The ORF’s with readily identifiable
functions were annotated using a variety of bioinformatics programs analyzing both
nucleotide and amino acid sequences, and are described in the Appendix. The genes are
numbered according to traditional phage genome organization and gene designations,
using the predicted genome organization of the excised prophage. The prophage is
organized with structural related genes on the canonical left arm, including terminase,
portal protein, tail and capsid proteins, and lysin A and lysin B. The canonical right arm
consists of replication related genes including primase and DNA polymerase. The
integrase cassette appears mostly intact, with a highly conserved integrase gene and two
potential repressors, gp54 and gp55. Multiple ORFs with potential transmembrane
domains were identified, including gp3 and gp67 (Figure 4).
The prophage contains genes related to a variety of mycobacteriophages, the most
common being singleton DS6A. DS6A is known to only infect Mycobacterium of the M.
tuberculosis complex, including M. bovis, M. africanum, M. canetti, and M. microti (19).
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HTH DNA
binding
domain

Integrase
AttL
Repressor

gp67: Band 7-like
transmembrane
protein

Portal
Terminase: Protein
large and
gp3:
transmembrane small
subunit
domain

AttR

Lysin A Lysin B

Figure 4. Gene map of the M. chelonae Bergey prophage. Not all predicted open
reading frames are shown. Important genes are annotated. The integrase cassette consists
of integrase, a repressor (gp54), and a short open reading frame containing a DNAbinding domain (gp55). Eight genes were predicted to contain membrane spanning
domains, only two are denoted on this gene map: gp67 and gp3. The lysis cassette
consists of Lysin A and Lysin B. Multiple structural genes were identified and are
colored green on the gene map. This gene map was generated using Phast (46).
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4.4 M. chelonae Bergey prophage contains two ORF’s containing DNA-binding
domains.
There are two ORF’s within the prophage that have helix-turn-helix domains that
are potential DNA-binding domains. These ORF’s lay within the integrase cassette and
are therefore strong candidates for regulators of the transition between lytic and lysogenic
lifestyles.
Gp54 is transcribed in the reverse direction, has high coding potential according
to GeneMark (3), and has strong sequence identity to a helix-turn-helix DNA binding
domain protein in cluster K phage Marcoliusprime. Analysis of the folding structure of
gp54 reveals that it folds similarly to transcriptional regulator EspR (Rv3849) in M.
tuberculosis (Figure 5) which adopts a traditional helix-turn-helix conformation.
Traditional helix-turn-helix domains are comprised of a core of three helices, with the
core helix domains packed closely together when dimerized. Upon dimerization the 2nd
and 3rd helices in the core domain will interact with the major groove of the target DNA
(2). The helix-turn-helix domain is located at the N-terminus, with 15 out of 17 of the
same amino acids involved in the helix-turn-helix as in the EspR known secondary
structure (Figure 6). EspR positively controls the ESX-1 delivery system, which delivers
important effector proteins to host cells during M. tuberculosis infection and is an
important virulence factor (36).
The second ORF with a predicted helix-turn-helix domain, gp55, is oriented in the
forward direction, has high coding potential according to GeneMark (3), and has
significant similarities to lambda phage repressor-like DNA binding domains as well as a
transcriptional regulator in V. cholera according to Phyre2 (24) (Figure 7). The HTH

25

domain is organized in a traditional manner (Figure 8). BLAST (31) analysis reveals
similarities to multiple HTH DNA binding domains in M. abscessus and some
mycobacteriophage. Gp55 also shows similarity to an antitoxin component in Prevotella
buccae according to Phyre2 (24) and to multiple types of antitoxins according to HHpred
(39). There is no prophage-encoded toxin component detected, but gp55 could be active
in suppressing translation of a host-encoded toxin.

B

A
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A

B
Helix 1

Helix 2
Helix 1

Helix 2
Helix 3

Helix 3

Figure 5. Predicted folding structure of M. chelonae prophage repressor gp54 (A)
compared to known folding structure of M. tuberculosis EspR (B). M. tuberculosis
EspR structure was solved using x-ray crystallography. Folding predictions were made
using Phyre2 (24).

Figure 6. Predicted secondary structure of gp54 compared to known secondary
structure of M. tuberculosis EspR. Amino acids 41 through 49 are involved in the
second helix and amino acids 60 through 69 are involved in the third helix. This helixturn-helix region is denoted by a red box. Folding predictions were made using Phyre2
(24).
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A

B

Helix 3

Helix 3
Helix 2

Helix 2

Helix 1

Helix 1

Figure 7. Predicted folding structure of M. chelonae prophage repressor gp55 (A)
compared to known folding structure of Lambda phage repressor DNA binding
domain (B). Lambda phage repressor structure was solved using x-ray crystallography.
Folding predictions were made using Phyre2 (24).

Figure 8. Predicted folding structure of gp55 compared to known secondary
structure of Lambda repressor DNA binding domains. The predicted helix-turn-helix
region is denoted by a red box with the second helix involving amino acids 49 through 56
and the third helix involving amino acids 67 through 86. Folding predictions were made
using Phyre2 (24).
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4.5 M. chelonae Bergey prophage contains multiple transmembrane proteins.
M. chelonae Bergey prophage contains 8 potential transmembrane proteins,
predicted using the online program TMHMM (25). Of these 8 potential proteins, gp3 and
gp67 are described below.
Gp3 contains one membrane spanning domain with high coding potential (Figure
9). It does not bear any resemblance to ORF’s in any other phages sequenced thus far. At
present, the function of this gene is unknown and is difficult to determine. There is a
moderate level of similarity to cystatin-like protein containing a nuclear transport factor-2
(NTF2) domain predicted by Phyre2 (24) (Figure 10) as well as HHpred (39). NTF
domains typically function as dimers and mediate the nuclear import of essential
molecules (34).
Gp67 has two membrane spanning domains (Figure 11) with high coding
potential and is highly similar to band-7-like membrane proteins in multiple phages from
clusters M, R, and C. Band-7 proteins are characterized by a highly-conserved sequence
motif known as the SPFH domain, named after membrane proteins stromatins,
prohibatins, flotillins, and the HflK protein. These proteins are known to modulate
membrane associated activities, including ion-channel function and vesicle trafficking.
The SPFH domain is highly conserved across all of nature, but its roll and function in
prokaryotes is poorly characterized (5). SPFH domains are generally characterized by an
alpha helical subdomain folded over a beta sheet subdomain with the two subdomains
connected by a hinge region. Although the common function of the SPFH domain has not
been identified, it is known to often function as a scaffolding protein on lipid membranes
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(27). Analysis of the predicted folding structure of gp67 (24) shows strong similarity to
stromatin and SPFH domains (Figure 12).
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Figure 9. Predicted alpha helix membrane spanning domain in gp3. Probability is
shown on the y-axis and amino acid numbers are shown on the x-axis. The membrane
spanning helix is shown in red and involves amino acids 7 through 29. Regions predicted
to lay inside the cell are denoted by a blue line and regions laying outside the cell are
denoted by a pink line. Transmembrane domain analysis was done using TMHMM (25).

A

B

Figure 10. Predicted tertiary structure of gp3 (A) compared to known crystal
structure of a putative dehydratase from the NTF2-like family from Streptomyces
avermitilis (B). S. avermitilis structure was solved using x-ray crystallography. Folding
predictions were made using Phyre2 (24).
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Figure 11. Predicted alpha helix membrane spanning domains in gp67. Probability is
shown on the y-axis and amino acid numbers are shown on the x-axis. Membrane
spanning helices are shown in red and involve amino acids 4 through 26 and amino acids
72 through 94. Regions predicted to lay inside the cell are denoted by a blue line and
regions laying outside the cell are denoted by a pink line. Transmembrane domain
analysis was done using the web program TMHMM (25).

A

B

Figure 12. Predicted tertiary structure of gp67 (A) compared to known crystal
structure of the core domain of stromatin from Pyrococcus horikoshii (B). P.
horikoshii structure was solved using x-ray crystallography. The N-terminal
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transmembrane region in both images is denoted by the red, orange, and yellow alpha
helix. Folding predictions are made using Phyre2 (24).
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4.6 M. chelonae Bowfin does not contain the prophage in the same position.
M. chelonae Bowfin was shown through PCR to be empty in the site where the
prophage lies in M. chelonae Bergey. Primers were designed to bind outside the prophage
region on the left and right. The PCR fragment produced when these primers were used
in M. chelonae Bowfin was approximately 600 bp, and was the result of amplification
across the empty attB site (Figure 13). The primers were confirmed to bind in M.chelonae
Bergey and amplified the left and right ends of the prophage.
4.7 M. chelonae Bowfin attB site is identical to M. chelonae Bergey attB.
The M. chelonae Bowfin attB site does not contain the prophage sequence. The
empty site was sequenced and shown to be 100% identical to M. chelonae Bergey attB.
The region flanking the left side of the Bowfin attB site is more variable, compared to the
M. chelonae Bergey attB site, than the rightward flanking region.
4.8 M. chelonae Bergey attB is highly conserved in singleton DS6A and in clusters K
and F.
M. chelonae Bergey attB is 100% identical to the DS6A attP, and highly
conserved in a number of K cluster phage, mostly K3 phage including TBond007,
ShedlockHolmes, and Pixie. The attP site is also highly conserved in F cluster phage,
particularly F1 cluster phage including Sparkdehlily, Zerg, and Whouxphf.
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Figure 13. Agarose gel electrophoresis of PCR products produced from prophage
PCR detection assay performed on M. chelonae strains. A combination of two sets of
primers were used. Each set was designed to flank the left and right ends of the prophage
with one primer laying within bacterial DNA and the other laying in prophage DNA,
denoted LF (left forward) and LR (left reverse), and RF (right forward) and RR (right
reverse). Lanes 2-4 contain M. chelonae Bowfin DNA with LF and LR used in lane 2, RF
and RR in lane 3, and LF and RR in lane 4. Lanes 5-7 contain M. chelonae Bergey DNA
with LF and LR in lane 5, RF and RR in lane 6, and LF and RR in lane 7. Lanes 8-10
contain M. chelonae isolated from a Fathead Minnow with LF and LR in lane 8, RF and
RR in lane 9, and LF and RR in lane 10. Lanes 11-13 contain M. chelonae F5 with LF
and LR in lane 11, RF and RR in lane 12, and LF and RR in lane 13. Lane 14 is a
negative control. Lanes 1 and 15 contain a 100 bp ladder.
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4.9 Prophage transmembrane protein and repressor are transcriptionally expressed
in Bergey.
RT-PCR analysis of RNA isolated from M. chelonae Bergey detected expression
of gp3, a predicted transmembrane protein, and gp54, a repressor (Figure 14). In addition
to these, four more primer sets were used in this experiment. These included gp7, gp52,
gp55, and gp67, which are predicted to be terminase, integrase, a repressor, and a
transmembrane protein. PCR with these primers did not detect any transcriptional
expression.
4.10 No infectious phage particles were detected using spot testing.
Because M. chelonae Bowfin has an empty attB sequence identical to M.
chelonae Bergey, Bergey prophage particles may be capable of infecting Bowfin. Spot
testing Bergey supernatant on Bowfin did not reveal any infectious prophage particles in
Bergey supernatant.
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Figure 14. Agarose gel electrophoresis of RT-PCR products using M. chelonae
Bergey RNA as template. Lane 2 contained gp3 primers and lane 5 contained gp54
primers. Lanes 3, 4, 6 and 7 contained primers for gp7, gp52, gp55 and gp67
respectively. Lane 8 is a negative control. A 100 bp ladder is shown in lane 1.
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5.0 Discussion
5.1 M. smegmatis MC2 155 prophage region 1 has strong potential to have
transcriptional regulatory action during and after infection.
Expression levels change drastically in prophage region 1 in the M. smegmatis
genome depending on lysogen status and time after lytic infection. These results strongly
suggest that the prophage encoded genes, including the MtrAB two-component
regulatory system and the type VII secretion system component, are up and
downregulated to modulate host functions during and after phage infections. These
prophage-encoded genes may have some role in modulating the host cell response to
changes in the environment or in modulating the host cell wall permeability (1). It should
be noted that it is still unclear if the MtrAB system is prophage encoded, or if the phage
simply integrated adjacent to this two component regulatory system. In either case, the
prophage is likely to have an impact on the expression of the MtrAB system. In a C.
glutamicum model, deletion mutants of MtrAB had noticeably different cell morphology
and were more sensitive to penicillin, vancomycin, and lyosozyme. Introducing plasmidencoded copies of mtrAB reversed these changes (29). The phage-encoded mtrAB system
could be offering the benefit of resistance to these antimicrobial agents to M. smegmatis.
5.2 The M. chelonae Bergey prophage may provide superinfection immunity against
DS6A, and clusters F and K.
Characterization of the M. chelonae prophage revealed that many open reading
frames showed similarity to a common mycobacteriophage; DS6A. This phage is a
singleton and is known to only infect Mycobacterium of the M. tuberculosis complex
(19). A minority of genes were most related to DS6A, while the rest were related to many
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different clusters and subclusters, most commonly clusters F and K. This is interesting in
part because this multi-cluster origin is true of singletons in general, but also because it
serves as a predictor of which clusters the prophage may offer some level of
superinfection immunity to. In this case, the prophage may offer immunity against
clusters F and K. While these are good predictions based on current information, the
continual sequencing of more phage genomes will provide a better understanding of the
prophage’s origins and potential cluster designation.
5.3 The M. chelonae Bergey prophage integration is recent.
Characterization of the M. chelonae Bergey prophage revealed an intact
mycobacteriophage with conserved genome structure, complete with notable cassettes
such as the integrase and lysis cassettes. The prophage also contains highly conserved
individual genes, including repressors, transmembrane proteins, structural proteins such
as capsid and tail proteins, and important enzymes such as a HNH endonuclease and
DNA methyltransferase. It was also shown that at least two prophage genes are
transcriptionally active, indicating that those two open reading frames are conserved to
such a high level that they are capable of being recognized by RNA polymerase. These
analyses suggest that the prophage integration is recent, assuming there is not
evolutionary pressure within the bacteria to conserve the entirety of the prophage.
5.4 The M. chelonae prophage has the potential to affect the biology of the host.
The high conservation of the prophage along with the discovery that at least two
genes are transcriptionally active shows the prophage has retained the ability to be
expressed on the transcriptional level. This suggests that the prophage might have a
greater impact on the host than was previously thought. Expression of these two prophage
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genes, transmembrane protein gp3 and predicted repressor protein gp54, offer an
interesting area of study. If gp3 transcripts are translated and presented on the cell
membrane, it could be offering superinfection immunity to the host. Alternatively, gp3
could be providing some unknown benefit to the host. If potential repressor gp54 is fully
expressed, it could be repressing the prophage and preventing the phage from entering the
lytic lifecycle and lysing the cell. It could also be offering superinfection immunity by
binding foreign phage DNA and marking it for destruction.
It can be hypothesized that if gp3 and gp55 are transcriptionally active, it is likely
that more of the 95 total genes in the prophage are also transcriptionally active because
many of these genes are also highly conserved. For example, the putative antitoxin gp55
could function to suppress the translation of a host-encoded toxin component. The
prophage therefore has the potential to be affecting the host fitness levels in some way,
but it is too early in this research to better define the prophage’s function and role in the
bacterium.
5.5 Conclusions and Future work
Regarding the M. smegmatis prophage regions, more investigation is needed to
understand why prophage region 1 genes MSMEG_1872 through MSMEG_1975 are
significantly up and down regulated in response to viral infection. It could be that these
genes are modulating the host cell’s response to changes in the environment as well as
changing the host cell wall permeability.
In the intact M. chelonae Bergey prophage, it was shown that gp3 and gp54 were
transcriptionally active through RT-PCR. It is now necessary to determine the
transcriptional status of the entire prophage region in M. chelonae Bergey through
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RNAseq. This knowledge will provide deeper insight into the effect of the prophage on
the biology of the host bacterium and will help determine the level of conservation of the
prophage region.
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APPENDIX
Table 2. M. chelonae prophage coordinates, direction, and predicted functions.
ORF Start
1
1
2
230

Stop
228
538

Function
NKF
HNH endonuclease

Direction Length
FWD
228
FWD
309

3

691

1152

Transmembrane
domain

RVS

462

4
5
6

1149
1356
2554

1343
2348
3033

NKF
NKF
Terminase, small
subunit

RVS
RVS
FWD

195
993
195

7

3034

4776

Terminase, large
subunit

FWD

1743

8
9

4773
6247

6263
9804

Portal protein
Capsid maturation
protease

FWD
FWD

1491
3558

10
11
12
13

9824
10249
10560
11213

10192
10431
11180
12106

NKF
NKF
NKF
Major capsid protein

FWD
RVS
FWD
FWD

369
183
621
894

14
15
16
17
18
19
20
21
22
23
24
25
26
27

12123
12524
12988
13157
13422
13911
14598
15089
15468
20021
20971
22699
23127
25262

12527
12988
13167
13429
13844
14492
15056
15475
20024
20974
22698
23130
25262
27010

NKF
NKF
NKF
NKF
Assembly protein
Major tail subunit
NKF
NKF
Tapemeasure
Minor tail protein
Minor tail protein
Minor tail protein
Minor tail protein
Minor tail protein

FWD
FWD
FWD
FWD
FWD
FWD
FWD
FWD
FWD
FWD
FWD
FWD
FWD
FWD

405
465
180
273
423
582
459
387
4557
954
1728
432
2136
1749
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28
29
30
31
32
33
34
35
36
37

27079
27495
27886
29373
30471
30685
31001
31325
31642
32422

27498
27761
29376
30449
30683
31011
31321
31645
32337
33600

NKF
NKF
Lysin A
Lysin B
NKF
NKF
NKF
NKF
NKF
DNA polymerase III

FWD
FWD
FWD
FWD
FWD
FWD
FWD
FWD
FWD
FWD

420
267
1491
1077
213
327
321
321
696
1179

38
39
40
41
42

33612
34049
34483
35486
35804

33860
34483
35493
35686
36601

NKF
NKF
NKF
NKF
Transcription factor

RVS
RVS
RVS
RVS
FWD

249
1011
1011
201
798

43

36659

37027

DNA binding domain,
transcription factor

FWD

369

44
45
46
47
48
49
50

37009
37397
39093
39485
39814
40233
40885

37311
38902
39284
39682
40167
40880
43086

NKF
NKF
NKF
NKF
NKF
NKF
HNH Endonuclease

FWD
RVS
RVS
FWD
RVS
RVS
RVS

303
1506
192
198
354
648
2202

51
52
53
54
55

43094
43910
45461
45815
46574

43411
45382
45805
46309
46885

NKF
Integrase
NKF
Repressor
Helix-turn-helix DNA
binding domain

RVS
FWD
FWD
RVS
FWD

318
1473
345
495
312

56
57

46885
47121

47121
48479

NKF
DNA methyl
transferase

FWD
FWD

237
1359

48

58
59
60
61
62

48476
49286
49393
49709
50257

49243
49393
49716
50257
50784

NKF
NKF
NKF
NKF
DNA polymerase III
subunit

FWD
FWD
FWD
FWD
FWD

768
108
324
549
417

63
64

50781
51194

51197
51913

NKF
Helix-turn-helix DNA
binding domain

FWD
FWD

417
720

65
66
67

51910
52185
53149

52188
53114
54129

NKF
NKF
Band 7-like
transmembrane protein

FWD
FWD
FWD

279
930
981

68

54126

54473

MazG nucelotide
pyrophosphohydrolase

FWD

348

69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87

54470
54958
55213
55852
56058
56285
56991
57362
57487
57738
57998
58448
59187
59657
60088
60261
60708
62342
62668

54961
55146
55677
56061
56285
56998
57302
57490
57735
58001
58243
58999
59654
60088
60207
60695
62345
62683
63135

NKF
NKF
NKF
NKF
NKF
Primase
NKF
NKF
NKF
NKF
NKF
NKF
NKF
NKF
NKF
NKF
NKF
NKF
Endodeoxyribonuclease

FWD
FWD
FWD
FWD
FWD
FWD
FWD
FWD
FWD
FWD
FWD
FWD
FWD
FWD
FWD
FWD
FWD
FWD
FWD

492
189
465
210
228
714
312
129
249
264
246
552
468
432
120
435
1638
342
468

49

88
89
90
91
92
93

63129
63265
63519
63877
64785
65358

63275
63519
63884
64788
65159
66782

NKF
NKF
NKF
NKF
NKF
Glycosyltransferase

FWD
FWD
FWD
FWD
FWD
FWD

147
255
366
912
375
1425

94
95

66779
67453

67456
68166

NKF
NKF

FWD
FWD

678
714
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